相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Evaluation of Allele-Specific PCR and Immunohistochemistry for the Detection of BRAF V600E Mutations in Hairy Cell Leukemia
Noah A. Brown et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
The Utility of BRAF V600E Mutation-Specific Antibody VE1 for the Diagnosis of Hairy Cell Leukemia
Guldeep Uppal et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity
Valentina Pettirossi et al.
BLOOD (2015)
Phospho-ERKTHR202/Tyr214 Is Overexpressed in Hairy Cell Leukemia and Is a Useful Diagnostic Marker in Bone Marrow Trephine Sections
Douglas W. Warden et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia
Ayse U. Akarca et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia
Enrico Tiacci et al.
HAEMATOLOGICA (2013)
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation A Model for qPCR Testing without Standard Curves
Philippe Szankasi et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides
Georgia Levidou et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins
N. J. Weston-Bell et al.
LEUKEMIA (2013)
Clinicopathological relevance of BRAF mutations in human cancer
Sahar Pakneshan et al.
PATHOLOGY (2013)
Hairy Cell Leukemia-New Genes, New Targets
Robert J. Kreitman
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2013)
Investigation of the BRAF V600E Mutation by Pyrosequencing in Lymphoproliferative Disorders
Javier A. Laurini et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Rapid Detection and Quantitation of BRAF Mutations in Hairy Cell Leukemia Using a Sensitive Pyrosequencing Assay
Shalini Verma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Application of a BRAF V600E Mutation-specific Antibody for the Diagnosis of Hairy Cell Leukemia
Mindaugas Andrulis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms
Luca Arcaini et al.
BLOOD (2012)
Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation
Liqiang Xi et al.
BLOOD (2012)
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia
Enrico Tiacci et al.
BLOOD (2012)
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Antonella De Luca et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
Jeremy S. Logue et al.
GENES & DEVELOPMENT (2012)
Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders
Piers A. Blombery et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia
Mark Ewalt et al.
HEMATOLOGICAL ONCOLOGY (2012)
pERK activation in esophageal carcinomas: Clinicopathological associations
K. E. Tasioudi et al.
PATHOLOGY RESEARCH AND PRACTICE (2012)
PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma
Erika F. Rodriguez et al.
ACTA NEUROPATHOLOGICA (2011)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies
Elaine M. Boyd et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
ERK Crosstalks with 4EBP1 to Activate Cyclin D1 Translation during Quinol-Thioether-Induced Tuberous Sclerosis Renal Cell Carcinoma
Jennifer D. Cohen et al.
TOXICOLOGICAL SCIENCES (2011)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
Detection of miR-106a in gastric carcinoma and its clinical significance
Bingxiu Xiao et al.
CLINICA CHIMICA ACTA (2009)
Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations
Maria Karlou et al.
PATHOLOGY (2009)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Integrative genomic approaches identify IKBKE as a breast cancer oncogene
Jesse S. Boehm et al.
CELL (2007)
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
S. Meloche et al.
ONCOGENE (2007)
AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling
Markus J. Riemenschneider et al.
CANCER RESEARCH (2006)
Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK
CH Chen et al.
EMBO JOURNAL (2005)
S6K1-/-/S6K2-/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway
M Pende et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Fibronectin protects prostate cancer cells from tumor necrosis factor-α-induced apoptosis via the AKT/survivin pathway
M Fornaro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations
P Korkolopoulou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf
K Mercer et al.
ONCOGENE (2002)
The S6 kinase signaling pathway in the control of development and growth
G Thomas
BIOLOGICAL RESEARCH (2002)
Prognostic evaluation of the microvascular network in myelodysplastic syndromes
P Korkolopoulou et al.
LEUKEMIA (2001)
分享论文
